A pharmaceutical composition of tizanidine in liquid form for use in therapy for intranasal administration characterized by containing active ingredient in its hydrochloride, dissolved in an aqueous solution and a buffer solution at a value selected pH in the range of 4.8 to 7.4, by the fact that the obtained solution, properly sterilized by heat treatment or a suitable preservative is added it can be administered as such or optionally added with one or more flavoring agents, tonicity agents, hyperbaric agents and enhancing agents suitable absorption commonly used.
展开▼